Trial intelligence / Profile preview

Dasatinib switch study in chronic-phase CML patients with chronic low-grade imatinib toxicity

2011-006180-21Phase 4Completed

Sponsor

Bristol Myers Squibb

Start

Jan 2013

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1